Junqi He

4.1k total citations · 1 hit paper
87 papers, 3.4k citations indexed

About

Junqi He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junqi He has authored 87 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Junqi He's work include Receptor Mechanisms and Signaling (12 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Junqi He is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Junqi He collaborates with scholars based in China, United States and United Kingdom. Junqi He's co-authors include Dong Chen, Fangqiong Tang, Xu Teng, Xinglu Huang, Randy A. Hall, Huiyu Liu, Linlin Li, Jianguo Xu, Amanda M. Castleberry and Junfang Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Junqi He

82 papers receiving 3.3k citations

Hit Papers

The effect of the shape o... 2009 2026 2014 2020 2009 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Junqi He 1.7k 777 672 635 300 87 3.4k
Lan Yuan 1.5k 0.9× 921 1.2× 781 1.2× 380 0.6× 152 0.5× 111 3.6k
Mihee Kim 1.9k 1.1× 422 0.5× 823 1.2× 685 1.1× 303 1.0× 75 4.0k
Abhijit Ray 1.8k 1.1× 994 1.3× 799 1.2× 474 0.7× 143 0.5× 116 4.2k
Xuan Wang 1.0k 0.6× 431 0.6× 1.2k 1.8× 1.2k 1.8× 228 0.8× 156 3.8k
Kazunori Ishimura 1.1k 0.7× 581 0.7× 780 1.2× 626 1.0× 213 0.7× 133 3.3k
Xue Xue 1.1k 0.7× 397 0.5× 701 1.0× 475 0.7× 176 0.6× 93 3.0k
Tongkai Chen 1.1k 0.7× 743 1.0× 1.1k 1.6× 804 1.3× 93 0.3× 81 3.5k
Zhihao Wu 1.6k 0.9× 248 0.3× 1.1k 1.6× 400 0.6× 183 0.6× 101 3.5k
Ji Li 2.1k 1.3× 475 0.6× 785 1.2× 303 0.5× 437 1.5× 233 5.7k

Countries citing papers authored by Junqi He

Since Specialization
Citations

This map shows the geographic impact of Junqi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqi He more than expected).

Fields of papers citing papers by Junqi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqi He. The network helps show where Junqi He may publish in the future.

Co-authorship network of co-authors of Junqi He

This figure shows the co-authorship network connecting the top 25 collaborators of Junqi He. A scholar is included among the top collaborators of Junqi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqi He. Junqi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Junqi, et al.. (2025). Comparative analysis of AI models in disseminating genetic counseling knowledge for gynecologic cancers. International Journal of Gynecology & Obstetrics. 170(3). 1408–1410.
2.
Chen, Yibin, Ying Yang, Ran Song, et al.. (2025). MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker. Cell Death and Disease. 16(1). 102–102. 1 indexed citations
3.
Tang, Fan, et al.. (2025). A targetable OSGIN1 − AMPK − SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis. npj Precision Oncology. 9(1). 15–15. 5 indexed citations
4.
He, Junqi, et al.. (2025). Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies. Frontiers in Pharmacology. 16. 1525733–1525733. 1 indexed citations
5.
Sun, Donglin, et al.. (2025). Cancer-associated fibroblasts in ovarian cancer: research progress. Frontiers in Oncology. 15. 1504762–1504762. 2 indexed citations
6.
Zhang, Lijie, et al.. (2024). PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway. British Journal of Cancer. 131(2). 347–360. 6 indexed citations
7.
Liu, Xiangxiang, Junqi He, Yonglin Wang, et al.. (2019). [Establishment of Flp-InTM CHO cell lines with double expression of CYP2A13 and MRP2].. PubMed. 35(10). 865–871. 1 indexed citations
8.
Wu, Zhifang, Fu Wang, Zhipeng Fan, et al.. (2019). Whole-Tooth Regeneration by Allogeneic Cell Reassociation in Pig Jawbone. Tissue Engineering Part A. 25(17-18). 1202–1212. 17 indexed citations
9.
Tao, Tao, Xiaomei Yang, Qiong Qin, et al.. (2017). NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells. International Journal of Molecular Sciences. 18(1). 5–5. 37 indexed citations
10.
Yang, Xiaomei, Guifang Du, Si Yang, et al.. (2017). A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. Anticancer Research. 37(1). 67–74. 11 indexed citations
11.
Wang, Yan, Zhiqiang Peng, Ran Meng, et al.. (2017). NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling. Oncology Reports. 38(1). 221–228. 16 indexed citations
12.
Zheng, Junfang, Zhiyu Yang, Longyan Yang, et al.. (2015). Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN. Oncology Reports. 35(1). 530–537. 8 indexed citations
13.
Feng, Duiping, Weihua Bian, Longyan Yang, et al.. (2012). EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation. Amino Acids. 43(5). 2027–2035. 33 indexed citations
14.
Jin, Luyuan, Lizheng Qin, Dengsheng Xia, et al.. (2012). Active secretion and protective effect of salivary nitrate against stress in human volunteers and rats. Free Radical Biology and Medicine. 57. 61–67. 48 indexed citations
15.
Huang, Xinglu, Xu Teng, Dong Chen, Fangqiong Tang, & Junqi He. (2009). The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials. 31(3). 438–448. 825 indexed citations breakdown →
16.
Zheng, Junfang, et al.. (2009). EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity. Amino Acids. 38(4). 1261–1268. 27 indexed citations
17.
Cheng, Shan, Ying Xiong, Yanmei Ma, et al.. (2008). A novel association of mGluR1a with the PDZ scaffold protein CAL modulates receptor activity. FEBS Letters. 582(30). 4117–4124. 25 indexed citations
18.
Cheng, Shan, Feng Qiu, Shuhui Wang, & Junqi He. (2007). HPLC analysis and pharmacokinetics of icariin in rats. Journal of Separation Science. 30(9). 1307–1312. 25 indexed citations
19.
Yang, Dong‐Hua, Elizabeth R. Smith, Isabelle Roland, et al.. (2002). Disabled-2 Is Essential for Endodermal Cell Positioning and Structure Formation during Mouse Embryogenesis. Developmental Biology. 251(1). 27–44. 140 indexed citations
20.
He, Junqi, Jianguo Xu, Amanda M. Castleberry, Anthony G. Lau, & Randy A. Hall. (2002). Glycosylation of β1-adrenergic receptors regulates receptor surface expression and dimerization. Biochemical and Biophysical Research Communications. 297(3). 565–572. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026